Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

由于与自身免疫性淋巴增生综合征（ALPS）Ib 型相关的杂合突变，导致 Fas 配体介导的细胞凋亡受到显性抑制